Zook Anthony P. 4

What Happened

• Anthony P. Zook, CEO of NeoGenomics (NEO), received two equity awards on March 1, 2026: 675,676 stock options and 406,918 restricted stock units (RSUs). These were reported on a Form 4 filed March 3, 2026. The filing shows the derivative awards at $0.00 for reporting purposes (they are grants, not purchases or sales).
• The stock options are "premium-price" options — the exercise price for the March 1, 2026 option grant is calculated as the closing price on February 27, 2026 multiplied by 110% (per the filing footnote). The RSUs will convert to common shares when they vest.

Key Details

• Transaction date: March 1, 2026 (Form 4 filed March 3, 2026).
• Awards granted: 675,676 stock options (derivative); 406,918 RSUs (derivative). Both types are reported as acquisitions (code A).
• Vesting: Both the March 1, 2026 options and RSUs vest ratably over the first three anniversaries of the grant date (footnotes F2 and F3). Earlier grants (April 1, 2025) had similar three‑year ratable vesting (footnotes F6–F7).
• Exercise price note: The March 1, 2026 option grant is a premium‑price option; exercise price = Feb 27, 2026 closing price × 110% (footnote F1). A prior option grant (4/1/2025) used that date’s close × 110% (F5). The filing does not list a dollar exercise price in the summary lines provided here.
• Shares owned after transaction: not specified in the information provided.
• Filing timeliness: Form 4 shows report date 3/1/2026 and filing date 3/3/2026; no late‑filing flag was provided in the materials you shared.

Context

• These transactions are grants (compensation awards), not purchases or sales — they don't represent an immediate cash investment or cashing out by the insider. Options give the right to buy shares later at an exercise price; RSUs convert to common stock when vested.
• Such grants are common elements of executive pay packages and do not, by themselves, indicate a buy or sell signal. For retail investors, purchases by insiders are often a clearer bullish signal; awards primarily reflect company compensation decisions.